Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?
Authors:
Open Access
- 16 December 2025
- journal article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 52 (1) , 101721
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Automated insulin delivery for people living with Type 1 Diabetes in France: A long road aheadDiabetes & Metabolism, 2025
- The role of automated insulin delivery technology in diabetesDiabetologia, 2024
- Insulin: evolution of insulin formulations and their application in clinical practice over 100 yearsActa Diabetologica, 2022
- Patch Pumps: What are the advantages for people with diabetes?Diabetes Research and Clinical Practice, 2022
- The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2021
- Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort studyDiabetologia, 2019
- Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicityBiomedicine & Pharmacotherapy, 2018
- Global trends in diabetes complications: a review of current evidenceDiabetologia, 2018
- The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approachThe European Journal of Health Economics, 2017
- Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapyDiabetes & Metabolism, 2010